-+ 0.00%
-+ 0.00%
-+ 0.00%

MONTE ROSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FOR MRT-8102 IN GFORCE-1 PHASE 1 STUDY SHOWING NORMALIZATION OF KEY PATHOGENIC DRIVERS OF ASCVD IN SUBJECTS WITH ELEVATED CVD RISK

Reuters·10/01/2026 11:00:02

Please log in to view news